Literature DB >> 10698826

Low dopamine D(2) receptor binding potential in social phobia.

F R Schneier1, M R Liebowitz, A Abi-Dargham, Y Zea-Ponce, S H Lin, M Laruelle.   

Abstract

OBJECTIVE: This study compared dopamine D(2) receptor binding potential in patients with social phobia and healthy comparison subjects.
METHOD: Dopamine D(2) receptor binding potential was assessed in 10 unmedicated subjects with generalized social phobia and no significant lifetime psychiatric comorbidity and 10 healthy comparison subjects matched for age and sex. Binding potential was measured in the striatum by using single photon emission computerized tomography and constant infusion of the D(2) receptor radiotracer [(123)I]iodobenzamide ([(123)I]IBZM).
RESULTS: Mean D(2) receptor binding potential was significantly lower in the subjects with social phobia than in the comparison subjects. Within the social phobia group, there was a nonsignificant correlation of binding potential with the Liebowitz Social Anxiety Scale score.
CONCLUSIONS: Generalized social phobia may be associated with low binding of [(123)I]IBZM to D(2) receptors in the striatum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698826     DOI: 10.1176/appi.ajp.157.3.457

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  67 in total

Review 1.  Unmasking social anxiety disorder.

Authors:  M B Stein; J M Gorman
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 2.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

Review 3.  Animal models of anxiety disorders.

Authors:  Joachim D K Uys; Dan J Stein; Willie M U Daniels; Brian H Harvey
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

4.  Additive effects of the dopamine D2 receptor and dopamine transporter genes on the error-related negativity in young children.

Authors:  A Meyer; D N Klein; D C Torpey; A J Kujawa; E P Hayden; H I Sheikh; S M Singh; G Hajcak
Journal:  Genes Brain Behav       Date:  2012-06-28       Impact factor: 3.449

5.  Effects of acute or chronic administration of novel 3,4-dimethoxyphenylethylamine derivates on anxiety-like behavior.

Authors:  Julia Fedotova; Victoria Barishpolec; Anthony Zulli; Dietrich Büsselberg; Ludovit Gaspar; Peter Kruzliak
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

6.  Striatal dopamine type 2 receptor availability in anorexia nervosa.

Authors:  Allegra Broft; Mark Slifstein; Joseph Osborne; Paresh Kothari; Simon Morim; Rebecca Shingleton; Lindsay Kenney; Shankar Vallabhajosula; Evelyn Attia; Diana Martinez; B Timothy Walsh
Journal:  Psychiatry Res       Date:  2015-07-26       Impact factor: 3.222

7.  Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.

Authors:  Sarah A Eisenstein; Jon M Koller; Marilyn Piccirillo; Ana Kim; Jo Ann V Antenor-Dorsey; Tom O Videen; Abraham Z Snyder; Morvarid Karimi; Stephen M Moerlein; Kevin J Black; Joel S Perlmutter; Tamara Hershey
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

8.  Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons.

Authors:  Norifumi Shioda; Yoshiki Imai; Yasushi Yabuki; Wataru Sugimoto; Kouya Yamaguchi; Yanyan Wang; Takatoshi Hikida; Toshikuni Sasaoka; Michihiro Mieda; Kohji Fukunaga
Journal:  J Neurosci       Date:  2019-08-01       Impact factor: 6.167

9.  Anxiety disorders and drug dependence: evidence on sequence and specificity among adults.

Authors:  Renee D Goodwin; Dan J Stein
Journal:  Psychiatry Clin Neurosci       Date:  2013-04       Impact factor: 5.188

10.  Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli.

Authors:  Andrea Kobiella; Sabine Vollstädt-Klein; Mira Bühler; Caroline Graf; Hans-Georg Buchholz; Nina Bernow; Igor Y Yakushev; Christian Landvogt; Mathias Schreckenberger; Gerhard Gründer; Peter Bartenstein; Christoph Fehr; Michael N Smolka
Journal:  Hum Brain Mapp       Date:  2010-05       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.